Quality
We test both efficacy and safety features of your chemicals through cell-based assays and 3R-based in vivo behavioral assessments.
Adaptability
We offer both well validated and « out-of-the-box-thinking » assays/models of CNS diseases in order to adapt to our customer’s demand.
EXPERIENCE
Our preclinical CRO has an 8 year expertise in the field of neurotoxicity in vivo and in vitro testing, behavioral phenotyping & psychopharmacology in mice.
Our Services
NB PharmaTox offers off-the shelf and customized services to public and private companies dealing with neurotoxicity risk assessment of chemicals, efficacy / safety of CNS pharmaceuticals, with the aim to support regulatory purposes
and drug development programs.
Human & murine in vitro testing: Neurotoxicity & Developmental Neurotoxicity
We make a point of offering both murine and human cell-based assays allowing screening strategies in developmental neurotoxicity (DNT) testing
Mice behavioral in vivo testing: Neurotoxicity & Developmental
Neurotoxicity
We perform Neurotoxicity & Developmental Neurotoxicity testing for your risk assessment studies.
Efficacy of CNS Pharmaceuticals
We propose various mice models of CNS diseases – of developmental or adult origin – and new models of neuropsychiatric disturbances resulting from environmental exposures.
Behavioural Phenotyping Services
We caracterize CNS disturbances in your mouse model of disease through 3Rs-based and ethologically relevant approaches.